Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2001
05/15/2001US6232522 Non-human animal model for systemic lupus erythematosis
05/15/2001US6232461 Used to generate transgenic plants tolerant to multiple environmental stresses such as drought or freezing
05/15/2001US6232460 Isolated nucleic acid molecule which encodes an SCP-1 mutein
05/15/2001US6232459 Synaptojanin isoform
05/15/2001US6232458 Proteins used in pharmaceutical human and veterinary applications; adapted to provide enhanced expression
05/15/2001US6232454 Nucleic acid and amino acid sequences and use in diagnosis, treatment, and prevention of cancer and immune disorders
05/15/2001US6232453 Gene encoding a polypeptide having pre-B cell growth-supporting ability
05/15/2001US6232452 Autosomal dominant disorder of growths in many tissues and organs identified on chromosome 16 deletion mutations; use in disease diagnosis and screening; the gene may behave as a tumor suppressor
05/15/2001US6232449 Persephin and related growth factors
05/15/2001US6232447 Antibody immunoreactive with a human cytokine designated LERK-6
05/15/2001US6232446 Antibody to human tumor necrosis factor (tnf) binding protein which binds to extracellular domain of the c-terminal cysteine loop of the receptor; inhibit cytotoxic effect but not its binding to the receptor
05/15/2001US6232445 Soluble MHC complexes and methods of use thereof
05/15/2001US6232443 Useful markers in diagnosing and monitoring cancerous renal cells; detecting cell proliferative disorders
05/15/2001US6232442 For capped rna; given amino acid substitutions; usseful for modifying protein expression levels; treatment of breast cancer
05/15/2001US6232441 PIGR-1, a member of immunoglobulin gene superfamily
05/15/2001US6232440 Of given amino acid sequence; screening for agonists and antagonists; use in diagnosis, prevention and treatment of cancer, immune disorders, and neurological disorders
05/15/2001US6232439 Bacillus thuringiensis isolates with broad spectrum activity
05/15/2001US6232438 Angiotensin converting enzyme inhibitors
05/15/2001US6232437 Detection of normal and abnormally phosphorylation in brain extracts and non-concentrated cerebrospinal fluid; immunological complex specific and preferential; use in diagnosis of alzheimer's disease
05/15/2001US6232292 3-dehydroquinate synthase
05/15/2001US6232291 Cytostatin III
05/15/2001US6232286 Methods of stimulating mitogenesis in glial cells using glial mitogenic factors
05/15/2001US6232123 Immunoglobulin for the diagnosis and treatment of tumors, leukemias, lymphomas and autoimmune diseases
05/15/2001US6232118 Nucleic acid encoding a protein of defined amino acid sequence; recombinant cell culture production; diagnosis; probes; treatment of parkinson's disease and other nervous system disorders with reduced side effects; gene therapy
05/15/2001US6232117 Expression vector wchich codes preferential controlling protein associated with transformation; for use as tool in genetic engineering
05/15/2001US6232116 Oral administration of pneumococcal antigens
05/15/2001US6232107 Nucleotide sequence coding green fluorescent protein; for use in diagnosis of microorganism infection
05/15/2001US6232106 DNA sequence encoding enzymes of clavulanic acid biosynthesis
05/15/2001US6232105 Conditional replication and expression system
05/15/2001US6232100 Nucleotide sequence which codes for hormone-regulating neuropeptide; diagnosis and therapy of nervous system disorders; probes; primers
05/15/2001US6232099 Method of producing a chimeric protein
05/15/2001US6232098 Kunitz domain polypeptide and materials and methods for making it
05/15/2001US6232096 Flea serine protease nucleic acid molecules and uses thereof
05/15/2001US6232095 Recombinant helix modification recognition proteins and uses thereof
05/15/2001US6232094 DNA encoding human κ casein and process for obtaining the protein
05/15/2001US6232089 CD23 processing enzyme preparation
05/15/2001US6232086 Method for detecting cancer cells
05/15/2001US6232084 Competitive binding
05/15/2001US6232082 Vaccines
05/15/2001US6232081 Complexing with slimb protein
05/15/2001US6232073 Nucleic acid marker for cancer
05/15/2001US6232071 Tenascin-C nucleic acid ligands
05/15/2001US6232069 RNA probe for detecting c-fes mRNA
05/15/2001US6232064 Fibrosis and atherosclerosis determination
05/15/2001US6232061 Detecting hybridization signals with probes; genetic engineering; identifying dna sequences that code for evolutionary conserved amino acid sequences
05/15/2001US6231869 Compounds and methods for the diagnosis and treatment of ehrlichia infection
05/15/2001US6231868 Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts
05/15/2001US6231864 Strategically modified hepatitis B core proteins and their derivatives
05/15/2001US6231863 DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
05/15/2001US6231862 Purified new epididymal forward motility protein and a process for the isolation of the said epididymal forward motility protein useful as a fertility prometer/blocker
05/15/2001US6231861 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
05/15/2001US6231851 Methods and compositions for the dry powder formulation of interferons
05/15/2001US6231850 Canine interleukin 12
05/15/2001CA2291456A1 Diagnostic agents for pancreatic exocrine function
05/15/2001CA2183268C Bispecific molecules having clinical utilities
05/15/2001CA2180011C Botulinum toxins for treating sweating
05/15/2001CA2078858C Expression of heterologous protein in yeast
05/15/2001CA2041638C Recombinant polynucleotide constructs suitable for providing secretion of pai-2
05/15/2001CA1341234C Recombinant fowlpox virus
05/15/2001CA1341231C Primary biliary cirrhosis autoantigen
05/15/2001CA1341229C Procoagulant proteins derived from factor viii: c
05/15/2001CA1341228C Expression of protein c
05/15/2001CA1341227C Human transforming growth factor alpha
05/10/2001WO2001033221A1 Axor35, a g-protein coupled receptor
05/10/2001WO2001032927A2 Tissue specific genes of diagnostic import
05/10/2001WO2001032926A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
05/10/2001WO2001032925A1 Modulation of neuroendocrine differentiation by protein 25.1
05/10/2001WO2001032921A2 Method of diagnosing rheumatoid arthritis
05/10/2001WO2001032920A2 Agents implicated in endometriosis
05/10/2001WO2001032918A1 Specific peptide substrate for human yak1, yak3a, and yak3b and yeast yak1 protein kinases
05/10/2001WO2001032910A2 27 human secreted proteins
05/10/2001WO2001032904A2 Method for enhancing secretion of beta-lactam compounds
05/10/2001WO2001032900A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins
05/10/2001WO2001032898A2 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
05/10/2001WO2001032895A1 Recombinant yeast strain for expressing human lactoferrin, n-lobe lactoferrin, c-lobe lactoferrin and process for preparation recombinant human lactoferrin, n-lobe lactoferrin, c-lobe lactoferrin using the same
05/10/2001WO2001032894A1 Cell surface display of proteins by recombinant host cells
05/10/2001WO2001032893A1 Recombinant therapeutic fusion proteins
05/10/2001WO2001032886A2 Starch branching enzymes
05/10/2001WO2001032884A2 Educational kit and method containing novel alpha helical protein-34
05/10/2001WO2001032883A2 Expression of the osa gene in transgenic plants confers resistance to agrobacterium transformation and crown gall disease
05/10/2001WO2001032882A2 Nucleic acids and proteins from group b streptococcus
05/10/2001WO2001032881A1 PHOTOSENSITIVITY GENE Hd1 OF PLANT AND UTILIZATION THEREOF
05/10/2001WO2001032880A1 Photosensitivity gene of plant and utilization thereof
05/10/2001WO2001032879A2 Method for producing recombinant interleucin-8 and interleucin-8 muteins
05/10/2001WO2001032878A2 A novel polypeptide hormone phosphatonin
05/10/2001WO2001032877A2 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO
05/10/2001WO2001032876A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions
05/10/2001WO2001032875A1 Torsin c nucleic acids and polypeptides
05/10/2001WO2001032874A2 Polypeptides and nucleic acids encoding same
05/10/2001WO2001032873A1 Insulin-responsive sequence dna binding protein-1' (irsdbp-1), gene encoding it and uses thereof
05/10/2001WO2001032872A2 Twik potassium channel molecules and uses therefor
05/10/2001WO2001032870A1 Novel human melastatin-like proteins and polynucleotides encoding the same
05/10/2001WO2001032869A1 HUMAN PROTEINS BINDING TO HUMAN TYROSINE KINASE Hck AND GENES ENCODING THE SAME
05/10/2001WO2001032868A1 Apm1 biallelic markers and uses thereof
05/10/2001WO2001032867A1 Polypeptides with expanded primary signalling motifs
05/10/2001WO2001032866A2 Hybrid adaptor receptors
05/10/2001WO2001032865A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences
05/10/2001WO2001032864A2 Gpcr-kd5 polypeptides and dna sequences thereof
05/10/2001WO2001032863A1 A novel polypeptide, a human apoptosis associated protein 12 and the polynucleotide encoding the polypeptide
05/10/2001WO2001032862A1 A novel polypeptide, a human s4 ribosome protein 20 and the polynucleotide encoding the polypeptide